Chemo comparison for certain ovarian tumors after surgery
Treatments studied
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This Phase 3 trial tests two chemotherapy regimens (TC vs BEP) for women with malignant sex cord-stromal tumors of the ovary. It aims to see which treatment works better after you’ve had initial surgery to diagnose and/or remove tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a Chinese woman, age 65 or younger
- You have a confirmed ovarian malignant sex cord-stromal tumor (specific subtypes like granulosa, Sertoli-Leydig, steroid cell, and others)
- Your ovarian cancer is newly diagnosed and stage IIA to IVB
- You had initial surgery within the last 8 weeks (for diagnosis, staging, or to reduce tumor)
- Your blood tests and organ function must be within required limits (enough white cells/platelets, and acceptable liver/kidney function)
- You should be able to do daily activities at a moderate level (Karnofsky score 60 or higher) and be able to sign consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial compares two different chemotherapy approaches for women with ovarian sex cord–stromal germ cell tumors. It aims to see which treatment works better and is safer for newly diagnosed stage IIA to IVB disease after surgery.
This Phase 3 trial studies a three-step “extra” chemotherapy plan after surgery for people with certain advanced ovarian, fallopian-tube, or primary peritoneal cancers. The goal is to improve outcomes by lowering the chance the cancer comes back.
This trial tests a different way of giving chemotherapy to people with advanced ovarian cancer that didn't respond well to initial treatment. The goal is to see if changing the dose and schedule can improve outcomes.
This trial compares two chemotherapy drugs (paclitaxel alone vs. paclitaxel plus carboplatin) given before surgery for advanced ovarian cancer. It is specifically for people whose tumors have a high level of the PARK2 gene, which may make them respond better to one of the treatments.
This trial tests adding propranolol (a heart medication) to standard chemotherapy before surgery for advanced high-grade serous ovarian cancer. The goal is to see if this combination helps shrink tumors more effectively.
This trial is testing a new drug, LBL-024, combined with chemotherapy (with or without a targeted therapy called bevacizumab) for ovarian cancer that has stopped responding to standard platinum-based treatment. The goal is to see if this combination can effectively shrink tumors and slow the disease's progression.
Hear when a new Ovarian Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.